EQUIFAX INC
For the period ended Sep 30, 2025. Filed Oct 21, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 21, 2025
EFX$188.23-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows—Nine Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| (In millions) | ||
| Operating activities: | ||
| Consolidated net income | $487.9 | $433.9 |
| Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 540.8 | 506.9 |
| Stock-based compensation expense | 63.9 | 71.9 |
| Deferred income taxes | 29.6 | (45.2) |
| Gain on sale of equity investment | (0.8) | — |
| Changes in assets and liabilities, excluding effects of acquisitions: | ||
| Accounts receivable, net | (45.6) | (47.8) |
| Other assets, current and long-term | (10.3) | (13.3) |
| Current and long term liabilities, excluding debt | 79.4 | 93.3 |
| Cash provided by operating activities | 1,144.9 | 999.7 |
| Investing activities: | ||
| Capital expenditures | (351.4) | (392.6) |
| Cash received from divestitures | 0.8 | — |
| Cash used in investing activities | (350.6) | (392.6) |
| Financing activities: | ||
| Net short-term payments | (204.1) | (195.9) |
| Payments on long-term debt | — | (695.6) |
| Proceeds from issuance of long-term debt | 1.7 | 649.8 |
| Treasury stock purchases | (427.4) | — |
| Dividends paid to Equifax shareholders | (172.0) | (144.8) |
| Distributions paid to noncontrolling interests | (6.2) | (4.4) |
| Proceeds from exercise of stock options and employee stock purchase plan | 38.1 | 67.5 |
| Payment of taxes related to settlement of equity awards | (13.6) | (16.4) |
| Debt issuance costs | — | (5.2) |
| Cash used in financing activities | (783.5) | (345.0) |
| Effect of foreign currency exchange rates on cash and cash equivalents | 8.3 | (10.7) |
| Increase in cash and cash equivalents | 19.1 | 251.4 |
| Cash and cash equivalents, beginning of period | 169.9 | 216.8 |
| Cash and cash equivalents, end of period | $189.0 | $468.2 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.